Clinical Rheumatology

Papers
(The H4-Index of Clinical Rheumatology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?91
COVID-19 and the clinical course of rheumatic manifestations88
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months82
Post-COVID-19 arthritis: a case report and literature review75
Ankylosing spondylitis risk factors: a systematic literature review62
Haemophagocytic syndrome and COVID-1958
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis56
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment52
Long COVID from rheumatology perspective — a narrative review50
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study46
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis44
Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study43
COVID-19 vaccination in immunocompromised patients42
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus37
Diagnostic delay in axial spondyloarthritis: a systematic review37
Dorsal root ganglia: fibromyalgia pain factory?34
Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)34
Clinical features and outcome of MIS-C patients: an experience from Central Anatolia34
Machine learning to identify immune-related biomarkers of rheumatoid arthritis based on WGCNA network34
Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children34
Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study33
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy32
Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis31
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review29
Mechanisms of thrombosis in ANCA-associated vasculitis29
Reactive arthritis before and after the onset of the COVID-19 pandemic28
Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions28
A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review27
Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean27
0.089210987091064